Cigna Group is leveraging AI and predictive analytics to achieve significant cost savings and improve patient outcomes. The company projects that its AI tools for identifying chronic conditions will save $200 million over three years by proactively connecting patients with clinicians. Additionally, Cigna is investing $100 million to reduce clinician documentation time and expedite prescriptions. The company has also successfully used AI to encourage patients to switch to more affordable biosimilar medications, leading to substantial savings for both patients and the company. AI
IMPACT Demonstrates how established companies are integrating AI for substantial cost savings and operational efficiencies in healthcare.
RANK_REASON Article details how an existing company is using AI for business value, not a new AI release or research.
- adalimumab
- Cigna Group
- Fortune
- Fortune AIQ 75
- Fortune AIQ Summit
- Katya Andresen
- New York Stock Exchange
- United States Food and Drug Administration
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →